Search by Drug Name or NDC

    NDC 69367-0197-60 Dexbrompheniramine Maleate and Phenylephrine Hydrochloride 2; 10 mg/1; mg/1 Details

    Dexbrompheniramine Maleate and Phenylephrine Hydrochloride 2; 10 mg/1; mg/1

    Dexbrompheniramine Maleate and Phenylephrine Hydrochloride is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Westminster Pharmaceuticals, LLC. The primary component is DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 69367-0197
    Product ID 69367-197_3cb2fbe4-e0ed-49e2-9668-4c5e8e43791c
    Associated GPIs 43993002500320
    GCN Sequence Number 066164
    GCN Sequence Number Description dexbrompheniramin/phenylephrin TABLET 2 MG-10 MG ORAL
    HIC3 Z2N
    HIC3 Description 1ST GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 28379
    HICL Sequence Number 036892
    HICL Sequence Number Description DEXBROMPHENIRAMINE MALEATE/PHENYLEPHRINE HCL
    Brand/Generic Generic
    Proprietary Name Dexbrompheniramine Maleate and Phenylephrine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dexbrompheniramine Maleate and Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2; 10
    Active Ingredient Units mg/1; mg/1
    Substance Name DEXBROMPHENIRAMINE MALEATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Westminster Pharmaceuticals, LLC
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 69367-0197-60 (69367019760)

    NDC Package Code 69367-197-60
    Billing NDC 69367019760
    Package 60 TABLET in 1 BOTTLE, PLASTIC (69367-197-60)
    Marketing Start Date 2018-10-25
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.4816
    Pricing Unit EA
    Effective Date 2021-02-17
    NDC Description DEXBROMPHENIR-PHENYLEPH 2-10 MG
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 4
    Classification for Rate Setting G
    As of Date 2022-02-16
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis